ORIGINAL RESEARCH
Published on 13 Aug 2025
Preexisting ulcerative colitis increases the risk of immune-related colitis and predicts divergent survival outcomes in gastrointestinal cancer patients treated with immune checkpoint inhibitors
doi 10.3389/fimmu.2025.1627680
- 290 views